SIRT1 Inhibition-Induced Mitochondrial Damage Promotes GSDME-Dependent Pyroptosis in Hepatocellular Carcinoma Cells
-
Published:2023-12-03
Issue:
Volume:
Page:
-
ISSN:1073-6085
-
Container-title:Molecular Biotechnology
-
language:en
-
Short-container-title:Mol Biotechnol
Author:
Liu Di, Liu Junhao, Liu Kejun, Hu Yanchao, Feng Jinming, Bu Yang, Wang QiORCID
Abstract
AbstractHepatocellular carcinoma (HCC) is a malignant tumor that affects the liver and poses a significant threat to human health. Further investigation is necessary to fully understand the role of SIRT1, a protein linked to tumorigenesis, in HCC development. To investigate the effect of SIRT1 on HCC and elucidate the underlying mechanism. Eight pairs of HCC and paracancerous normal tissue specimens were collected. The levels of SIRT1 and GSDME in tissue samples were assessed using immunohistochemistry and western blotting. SIRT1 levels were determined in HCC (Huh7, HepG2, SNU-423, SNU-398, and HCCLM3) and L-02 cells using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting. SNU-423 and HCCLM3 cells were transfected with si-SIRT1 and/or si-GSDME to knock down SIRT1 or GSDME expression. RT-qPCR and western blotting were performed to measure the expression of SIRT1, pro-casp-3, cl-casp-3, GSDME, GSDME-N, PGC-1α, Bax, and cytochrome c (Cyto C). Cell proliferation, migration, invasion, and apoptosis were assessed using the cell counting kit-8 (CCK-8), wound healing assay, Transwell invasion assay, and flow cytometry, respectively. The release of lactate dehydrogenase (LDH) was evaluated using an LDH kit. SIRT1 was upregulated in HCC tissues and cells, and a negative correlation was observed between SIRT1 and GSDME-N. SIRT1 silencing suppressed the proliferation, migration, and invasion of HCC cells while also promoting apoptosis and inducing mitochondrial damage. Additionally, the silencing of SIRT1 resulted in the formation of large bubbles on the plasma membrane of HCC cells, leading to cellular swelling and aggravated GSDME-dependent pyroptosis, resulting in an increase in LDH release. Inhibition of GSDME reduced SIRT1 silencing-induced cell swelling, decreased LDH release rate, and promoted apoptosis. SIRT1 silencing promotes GSDME-dependent pyroptosis in HCC cells by damaging mitochondria.
Funder
the Innovation Platform Fund Project of the Ningxia Hui Autonomous Region Science and Technology Infrastructure Construction Plan the Ningxia Hui Autonomous Region Science and Technology Innovation Leading Talents the Ningxia Hui Autonomous Region Natural Science Foundation in 2022
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference41 articles.
1. Sung, H., Ferlay, J., Siegel, R., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: ACancer Journal for Clinicians, 71, 209–249. 2. Su, C., Lin, Y., Cai, L., Mao, Q., & Niu, J. (2016). Association between mannose-binding lectin variants, haplotypes and risk of hepatocellular carcinoma: A case-control study. Scientific Reports, 6, 32147. 3. Tovoli, F., Negrini, G., & Bolondi, L. (2016). Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma. Hepatic Oncology, 3, 119–136. 4. Jia, P., Mao, Y., Liu, K., & Wei, X. (2022). The value of color doppler ultrasound and ct combined with serum afp examination in the diagnosis of hepatocellular carcinoma. Journal of Healthcare Engineering, 2022, 4147753. 5. Jianyong, L., Jinjing, Z., Lunan, Y., Jingqiang, Z., Wentao, W., Yong, Z., Bo, L., Tianfu, W., & Jiaying, Y. (2017). Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma. Scientific Reports, 7, 41624.
|
|